高强度聚焦超声治疗良性甲状腺结节的有效性:系统评价与Meta分析
该系统评价与Meta分析纳入32项研究,其中14项用于Meta分析,评估高强度聚焦超声治疗良性甲状腺结节的疗效与安全性。治疗后3、6、12个月平均体积缩小率分别为39.02%、48.55%、55.02%,6个月治疗成功率为75.8%,声带麻痹和Horner综合征发生率分别为2.1%和0.7%。作者认为HIFU是有效且安全的治疗选择,但大型及不同性质结节的效果需进一步研究。
要点
- HIFU治疗后6个月和12个月平均体积缩小率分别为48.55%和55.02%,6个月治疗成功率为75.8%。
- 声带麻痹和Horner综合征发生率分别为2.1%和0.7%,喉返神经麻痹、甲状腺功能减退和皮肤发红等并发症发生率低。
- 作者认为HIFU是良性甲状腺结节有效且安全的治疗选择,但大型及不同性质结节的效果需进一步研究。
核心结论
- HIFU是良性甲状腺结节有效且安全的治疗选择,但大型及不同性质结节的效果需进一步研究,且需开展长期随访的随机对照试验。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library,纳入32项研究,其中14项用于Meta分析(另18项因数据收集期重叠未纳入),采用随机效应模型评估体积缩小率、治疗成功率和治疗相关并发症发生率。
诊断标准与关键数值
- 治疗后3、6、12个月平均体积缩小率分别为39.02%(95%CI:27.57至50.47%,I²:97.9%)、48.55%(95%CI:35.53至61.57%,I²:98.2%)和55.02%(95%CI:41.55至68.48%,I²:99%);6个月治疗成功率为75.8%;声带麻痹和Horner综合征发生率分别为2.1%(95%CI:0.2至4.1%,I²:14.6%)和0.7%(95%CI:0至1.9%,I²:0%)。
局限性
- 仅14项研究用于Meta分析,另18项因数据收集期重叠未纳入。
- 3、6、12个月体积缩小率的异质性分别为I²:97.9%、I²:98.2%、I²:99%。
- HIFU对大型及不同性质结节的效果需进一步研究。
- 需开展长期随访的随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Thyroid nodules are common and sometimes associated with cosmetic issues. Surgical treatment has several disadvantages, including visible scarring. High-intensity focused ultrasound (HIFU) is a recent noninvasive treatment for thyroid nodules. The present study aims to evaluate the effectiveness and safety of HIFU for the treatment of benign thyroid nodules.
METHODS: We searched PubMed, Embase, and Cochrane Library for studies evaluating the outcomes of HIFU for patients with benign thyroid nodules. We conducted a meta-analysis by using a random effects model and evaluated the volume reduction ratio, treatment success rate, and incidence of treatment-related complications.
RESULTS: Thirty-two studies were included in the systematic review. Only 14 studies were used in the meta-analysis because the other 18 involved data collected during overlapping periods. The average volume reduction ratios at 3, 6, and 12 months after treatment were 39.02% (95% CI: 27.57 to 50.47%, I2: 97.9%), 48.55% (95% CI: 35.53 to 61.57%, I2: 98.2%), and 55.02% (95% CI: 41.55 to 68.48%, I2: 99%), respectively. Regarding complications, the incidences of vocal cord paresis and Horner's syndrome after HIFU were 2.1% (95% CI: 0.2 to 4.1%, I2: 14.6%) and 0.7% (95% CI: 0 to 1.9%, I2: 0%), respectively.
CONCLUSIONS: HIFU is an effective and safe treatment option for patients with benign thyroid nodules. However, the effects of HIFU on nodules of large sizes and with different properties require further investigation. Additional studies, particularly randomized controlled trials involving long-term follow-up, are warranted.
CLINICAL RELEVANCE STATEMENT: Surgical treatment for thyroid nodules often results in permanent visible scars and is associated with a risk of bleeding, nerve injury, and hypothyroidism. High-intensity focused ultrasound may be an alternative for patients with benign thyroid nodules.
KEY POINTS: • The success rate of HIFU treatment for thyroid nodules is 75.8% at 6 months. Average volume reduction ratios are 48.55% and 55.02% at 6 and 12 months. • The incidence of complications such as vocal fold paresis, Horner's syndrome, recurrent laryngeal nerve palsy, hypothyroidism, and skin redness is low. • HIFU is both effective and safe as a treatment for benign thyroid nodules.
引用
- Fan KY, Loh EW, Tam KW, et al. Efficacy of HIFU for the treatment of benign thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2023. PMID: 37792080. doi:10.1007/s00330-023-10253-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。